Thomas J. Schall, Director at Immuneering Corp (IMRX), bought 2,900 shares at $2.55 ($7K) on 2024-03-22, disclosed to the SEC on 2024-03-25.
Open-market purchase of $7k IMRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| IMRX | BUY | 2025-06-18 | $179K | — | Filing → |
| CCXI | SELL | 2022-08-08 | $6.5M | — | Filing → |
| CCXI | SELL | 2020-12-16 | $3.7M | — | Filing → |